Darbepoetin Alfa in Anemic Low or Intermediate-1 Risk MDS Subjects

Condition:   MDSInterventions:   Drug: Darbepoetin alfa;   Drug: PlaceboSponsor:   AmgenActive, not recruiting - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Anemia | Aranesp | Research